Overview

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in Asia. The aim of this trial is to compare the efficacy of postprandial plasma glucose of two treatment regimens in Chinese subjects.

Phase:

Phase 4

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Isophane
Insulin, Long-Acting
Isophane insulin, beef
Isophane Insulin, Human